CoChat

RasV12; scrib−/− Tumors: A Cooperative Oncogenesis Model Fueled by Tumor/Host Interactions

Open access
Dillard, Caroline, Reis, José Gerardo Teles, Rusten, Tor Erik · 2021 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Abstract

The phenomenon of how oncogenes and tumor-suppressor mutations can synergize to promote tumor fitness and cancer progression can be studied in relatively simple animal model systems such as Drosophila melanogaster. Almost two decades after the landmark discovery of cooperative oncogenesis between oncogenic RasV12 and the loss of the tumor suppressor scribble in flies, this and other tumor models have provided new concepts and findings in cancer biology that has remarkable parallels and relevance to human cancer. Here we review findings using the RasV12; scrib−/− tumor model and how it has contributed to our understanding of how these initial simple genetic insults cooperate within the tumor cell to set in motion the malignant transformation program leading to tumor growth through cell growth, cell survival and proliferation, dismantling of cell–cell interactions, degradation of basement membrane and spreading to other organs. Recent findings have demonstrated that cooperativity goes beyond cell intrinsic mechanisms as the tumor interacts with the immediate cells of the microenvironment, the immune system and systemic organs to eventually facilitate malignant progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22168873

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The cooperation between the oncogene RasV12 and loss of the tumor suppressor scribble drives the malignant transformation of eye disc epithelial cells. (A) Representation of a larva with most of its organs. An eye-antennal disc is composed of two main parts. The anterior part is the antennal part (white and grey), which will transform into the antenna and part of the head during metamorphosis. The posterior part is the eye part which generates the photoneurons (purple) in a synchronous manner after the morphogenetic furrow (purple line). (B) scrib−/− clones (green) form benign tumors characterized by a loss of cell polarity, resistance to differentiation into neurons (accompanied by a distortion of the morphogenetic furrow), overproliferation, and basement membrane degradation. Ultimately, they are eliminated through apoptosis. (C) RasV12 clones (green) form hyperplastic tumors (defined as tumors that overgrow without disrupting the tissue architecture and differentiation). They are characterized by overproliferation and cell growth. Because neuronal differentiation is not impaired within RasV12 clones, transformed cells differentiate synchronously to their wt neighbors (purple cells within the clones) at the morphogenetic furrow (thick purple line) and form long neuronal axons (purple lines) that extend through the posterior part of the eye disc in order to form the optic nerve. (D) RasV12; scrib−/− clones form neoplastic tumors (defined as tumors that disrupt the tissue morphology and impair differentiation). They are characterized by a loss of cell polarity, resistance to differentiation, overproliferation, cell growth, basement membrane degradation, and invasion. RasV12; scrib−/− tumors trigger a developmental delay, postponing pupation.
Figure 1 The cooperation between the oncogene RasV12 and loss of the tumor suppressor scribble drives the malignant transformation of eye disc epithelial cells. (A) Representation of a larva with most of its organs. An eye-antennal disc is composed of two main parts. The anterior part is the antennal part (white and grey), which will transform into the antenna and part of the head during metamorphosis. The posterior part is the eye part which generates the photoneurons (purple) in a synchronous manner after the morphogenetic furrow (purple line). (B) scrib−/− clones (green) form benign tumors characterized by a loss of cell polarity, resistance to differentiation into neurons (accompanied by a distortion of the morphogenetic furrow), overproliferation, and basement membrane degradation. Ultimately, they are eliminated through apoptosis. (C) RasV12 clones (green) form hyperplastic tumors (defined as tumors that overgrow without disrupting the tissue architecture and differentiation). They are characterized by overproliferation and cell growth. Because neuronal differentiation is not impaired within RasV12 clones, transformed cells differentiate synchronously to their wt neighbors (purple cells within the clones) at the morphogenetic furrow (thick purple line) and form long neuronal axons (purple lines) that extend through the posterior part of the eye disc in order to form the optic nerve. (D) RasV12; scrib−/− clones form neoplastic tumors (defined as tumors that disrupt the tissue morphology and impair differentiation). They are characterized by a loss of cell polarity, resistance to differentiation, overproliferation, cell growth, basement membrane degradation, and invasion. RasV12; scrib−/− tumors trigger a developmental delay, postponing pupation.CC BY · PubMed Central
Figure 2 Cooperative oncogenesis results from the atypical interplay of various signaling pathways that display several tumor cancer hallmarks. (A) In scrib−/− benign tumors, the JNK pathway (green) has an antitumorigenic function. It is activated by the TNF Eiger, which binds to the TNFR Wengen (Wgn). Elevated endocytosis levels contribute to activating the Eiger/Wgn complex that activates a phosphorylation event cascade involving successively the JNKKKK, JNKKK, and JNKK. Ultimately, the JNK Basket is phosphorylated and activates its downstream AP-1 TFs effectors. AP-1 TFs stimulates the expression of the proapoptotic factors rpr and hid, which execute apoptosis a well as paxillin and mmp1, which leads to basement membrane degradation. Simultaneously, the loss of cell polarity initiated by the loss of function of scribble provokes aPKC (blue) signaling impairment, which results in the activation of the SWH target Yki (orange). Yki together with Sd activates the expression of cyclinE and causes overproliferation. Finally, DE-cadherin expression decreases, contributing further to the loss of cell polarity phenotype. (B) In RasV12 hyperplastic tumors, the Scrib (grey) and aPKC (blue) apical complexes usually are localized close to the adherens junction and in the apical part, respectively. The aberrantly active RasV12 stimulates the downstream Raf/Mek/MAPK and PI3K/AKT pathways (purple) responsible for cyclinE (overproliferation) and dmyc (cell growth) overexpression, respectively. (C) In the RasV12; scrib−/− neoplastic tumors, JNK is protumorigenic. The upstream JNK signaling is not fully explored in the eye-antennal disc tumors yet. It seems to involve Eiger binding to Grnd mainly (and Wgn), which further activates the JNKKKK Msn, the JNKKK Tak1, the JNKK Hep, and Bsk. A parallel Src-dUev1/Ben/dTraf2 axis elevates the activity of Hep upstream of Bsk. The novel JNKK MMK3 and the nonreceptor tyrosine kinase FER might also contribute to Bsk activity. Bsk triggers the activation of the TFs Fos, Ets21c, and Ftfz1, which upregulate the expression of the BTBZF chinmo and abrupt (resistance to neuron differentiation), mmp1 and cher (basement membrane degradation and invasion), as well as dilp8 and upd (developmental delay). Whether they also elevate hid transcription is unknown. In parallel, lowering of SWH signaling leads to the activation of Yki (orange). Together with Sd, Yki activates the expression of dmyc (cell growth), cyclinE (proliferation), dilp8 and upd (developmental delay, not demonstrated) and of some other signaling components such as upd and stat (JAK-STAT pathway) as well as fos and ftzf1 (JNK pathway). RasV12 activates the Raf/Mek/MAPK and PI3K/AKT pathways, contributing to the expression of dmyc (cell growth) and cyclinE (proliferation). It also inhibits hid expression and Hid activity, protecting RasV12; scrib−/− cancer cells from apoptosis. Finally, tumor-secreted Upds activate the JAK-STAT pathway in an autocrine manner and contribute to ROS production and tumor growth through an unknown mechanism.
Figure 2 Cooperative oncogenesis results from the atypical interplay of various signaling pathways that display several tumor cancer hallmarks. (A) In scrib−/− benign tumors, the JNK pathway (green) has an antitumorigenic function. It is activated by the TNF Eiger, which binds to the TNFR Wengen (Wgn). Elevated endocytosis levels contribute to activating the Eiger/Wgn complex that activates a phosphorylation event cascade involving successively the JNKKKK, JNKKK, and JNKK. Ultimately, the JNK Basket is phosphorylated and activates its downstream AP-1 TFs effectors. AP-1 TFs stimulates the expression of the proapoptotic factors rpr and hid, which execute apoptosis a well as paxillin and mmp1, which leads to basement membrane degradation. Simultaneously, the loss of cell polarity initiated by the loss of function of scribble provokes aPKC (blue) signaling impairment, which results in the activation of the SWH target Yki (orange). Yki together with Sd activates the expression of cyclinE and causes overproliferation. Finally, DE-cadherin expression decreases, contributing further to the loss of cell polarity phenotype. (B) In RasV12 hyperplastic tumors, the Scrib (grey) and aPKC (blue) apical complexes usually are localized close to the adherens junction and in the apical part, respectively. The aberrantly active RasV12 stimulates the downstream Raf/Mek/MAPK and PI3K/AKT pathways (purple) responsible for cyclinE (overproliferation) and dmyc (cell growth) overexpression, respectively. (C) In the RasV12; scrib−/− neoplastic tumors, JNK is protumorigenic. The upstream JNK signaling is not fully explored in the eye-antennal disc tumors yet. It seems to involve Eiger binding to Grnd mainly (and Wgn), which further activates the JNKKKK Msn, the JNKKK Tak1, the JNKK Hep, and Bsk. A parallel Src-dUev1/Ben/dTraf2 axis elevates the activity of Hep upstream of Bsk. The novel JNKK MMK3 and the nonreceptor tyrosine kinase FER might also contribute to Bsk activity. Bsk triggers the activation of the TFs Fos, Ets21c, and Ftfz1, which upregulate the expression of the BTBZF chinmo and abrupt (resistance to neuron differentiation), mmp1 and cher (basement membrane degradation and invasion), as well as dilp8 and upd (developmental delay). Whether they also elevate hid transcription is unknown. In parallel, lowering of SWH signaling leads to the activation of Yki (orange). Together with Sd, Yki activates the expression of dmyc (cell growth), cyclinE (proliferation), dilp8 and upd (developmental delay, not demonstrated) and of some other signaling components such as upd and stat (JAK-STAT pathway) as well as fos and ftzf1 (JNK pathway). RasV12 activates the Raf/Mek/MAPK and PI3K/AKT pathways, contributing to the expression of dmyc (cell growth) and cyclinE (proliferation). It also inhibits hid expression and Hid activity, protecting RasV12; scrib−/− cancer cells from apoptosis. Finally, tumor-secreted Upds activate the JAK-STAT pathway in an autocrine manner and contribute to ROS production and tumor growth through an unknown mechanism.CC BY · PubMed Central
Figure 3 Local microenvironment interactions can act as suppressors or be exploited for tumor growth. (A) Anti-tumorigenic role of the microenvironment. scrib−/− tumors are actively eliminated by the neighboring cells through cell competition. Several mechanisms are put in place by the winner cells, the microenvironment, to restrict the growth and remove the loser cells, the scrib−/− tumors. (a) The expression of an inhibitor of the toll ligand Spz, Spn5, is critical in the microenvironment to maintain the loser status of scrib−/− tumors. Upon non-autonomous loss of spn5, Toll signaling, together with JNK and high F-actin levels, can elevate yki activity, an inducer of the winner status (shown in red). (b) Upon tumorigenesis, wt cells communicate with the tumor cells through the Sas-Ptp10D signaling axis to inhibit Egfr-Ras signaling, a pathway that can potently cooperate with polarity deficiency for malignancy. (c) Activation of JNK in the wt cells activates an engulfment program through PVR-ELMO/MBC which leads to the entosis of the scrib−/− tumors and their death. (B) Pro-tumorigenic role of the microenvironment. In a cooperative RasV12; scrib−/− scenario, the microenvironment is exploited to fuel tumor growth. (a) Caspase apoptotic induction is inhibited by RasV12; however, apoptotic-independent functions still remain active. RasV12; scrib−/− tumors exploit the mechanism behind apoptosis induced proliferation. Caspases, and potentially impaired mitochondria, can induce high levels of ROS, which triggers hemocyte recruitment. This mounts an inflammatory response that leads to higher JNK levels. (b) NAA is induced in the wt cells surrounding RasV12; scrib−/− tumors, through tumor autonomous JNK and the autocrine activation of JAK-STAT through Upd and Dome. Downregulation of the transporter slif in RasV12; dlg−/− showed that these tumors are dependent on exogenous nutrient sources, potentially released from the neighboring wt cells through NAA. (c) Areas that are nurturing or hindering for tumor growth, termed tumor “hotspots” and “coldspots”, respectively, have been identified in the wing disc. The tumor hotspot, which is in the wing disc hinge, was found to have high levels of JAK-STAT, a pathway critical for the RasV12; scrib−/− tumor growth, and apical extrusion which promotes tumor cell survival. (d) The RasV12; scrib−/− cooperative scenario is not restricted to an intraclonal setting. Neighboring scrib−/− clones to RasV12 tumors has been found to be sufficient to elevate JNK and JAK-STAT in RasV12 tumors, and to trigger their large overgrowth and invasion.
Figure 3 Local microenvironment interactions can act as suppressors or be exploited for tumor growth. (A) Anti-tumorigenic role of the microenvironment. scrib−/− tumors are actively eliminated by the neighboring cells through cell competition. Several mechanisms are put in place by the winner cells, the microenvironment, to restrict the growth and remove the loser cells, the scrib−/− tumors. (a) The expression of an inhibitor of the toll ligand Spz, Spn5, is critical in the microenvironment to maintain the loser status of scrib−/− tumors. Upon non-autonomous loss of spn5, Toll signaling, together with JNK and high F-actin levels, can elevate yki activity, an inducer of the winner status (shown in red). (b) Upon tumorigenesis, wt cells communicate with the tumor cells through the Sas-Ptp10D signaling axis to inhibit Egfr-Ras signaling, a pathway that can potently cooperate with polarity deficiency for malignancy. (c) Activation of JNK in the wt cells activates an engulfment program through PVR-ELMO/MBC which leads to the entosis of the scrib−/− tumors and their death. (B) Pro-tumorigenic role of the microenvironment. In a cooperative RasV12; scrib−/− scenario, the microenvironment is exploited to fuel tumor growth. (a) Caspase apoptotic induction is inhibited by RasV12; however, apoptotic-independent functions still remain active. RasV12; scrib−/− tumors exploit the mechanism behind apoptosis induced proliferation. Caspases, and potentially impaired mitochondria, can induce high levels of ROS, which triggers hemocyte recruitment. This mounts an inflammatory response that leads to higher JNK levels. (b) NAA is induced in the wt cells surrounding RasV12; scrib−/− tumors, through tumor autonomous JNK and the autocrine activation of JAK-STAT through Upd and Dome. Downregulation of the transporter slif in RasV12; dlg−/− showed that these tumors are dependent on exogenous nutrient sources, potentially released from the neighboring wt cells through NAA. (c) Areas that are nurturing or hindering for tumor growth, termed tumor “hotspots” and “coldspots”, respectively, have been identified in the wing disc. The tumor hotspot, which is in the wing disc hinge, was found to have high levels of JAK-STAT, a pathway critical for the RasV12; scrib−/− tumor growth, and apical extrusion which promotes tumor cell survival. (d) The RasV12; scrib−/− cooperative scenario is not restricted to an intraclonal setting. Neighboring scrib−/− clones to RasV12 tumors has been found to be sufficient to elevate JNK and JAK-STAT in RasV12 tumors, and to trigger their large overgrowth and invasion.CC BY · PubMed Central
Figure 4 RasV12; scrib−/− eye antennal disc tumors alter distant organ functions. Invasion: RasV12; scrib−/− tumors (green) invade adjacent organs such as the central nervous system (CNS) and the leg discs (LD). Invasion is guided by the interaction between the Toll6 receptor at the surface of invasive tumor cells and its ligand Spz, secreted by a subset of organs prone to secondary tumor formation. Developmental delay: It relies on the decrease of Ecdysone production by the prothoracic gland (PG). The tumor cells secrete Dilp8 and Upd3, which are both known for their ability to inhibit Ecdysone production. Inflammation: Tumor cells (green) have elevated ROS levels, attracting plasmatocytes (purple) to the basement membrane breach. These plasmatocytes secrete Eiger and contribute to mmp1 expression in the tumor cells and subsequently to their ability to escape the primary tumor, arguing for a pro tumorigenic function. Together with the fat body, they constitute the potential source of the AMP Drosomycin that is found elevated in the larval hemolymph. Drosomycin (Drs) triggers cell death in the tumor, arguing for a potential anti-tumorigenic role of the plasmatocytes. Wasting: Tumor cells secrete ImpL2 (and potentially Pvf and Bnl), which is thought to trigger a wasting phenotype in the larva characterized by the morphological deterioration of the energy-storing organs: the muscles (shrinkage and split) and the fat body (pearl-like phenotype, lipid droplet aggregation). This is accompanied by elevation of autophagy in these organs as well as elevated sugar and amino acid levels in the hemolymph. In its late stage, the tumor building blocks derive from host to maintain its growth.
Figure 4 RasV12; scrib−/− eye antennal disc tumors alter distant organ functions. Invasion: RasV12; scrib−/− tumors (green) invade adjacent organs such as the central nervous system (CNS) and the leg discs (LD). Invasion is guided by the interaction between the Toll6 receptor at the surface of invasive tumor cells and its ligand Spz, secreted by a subset of organs prone to secondary tumor formation. Developmental delay: It relies on the decrease of Ecdysone production by the prothoracic gland (PG). The tumor cells secrete Dilp8 and Upd3, which are both known for their ability to inhibit Ecdysone production. Inflammation: Tumor cells (green) have elevated ROS levels, attracting plasmatocytes (purple) to the basement membrane breach. These plasmatocytes secrete Eiger and contribute to mmp1 expression in the tumor cells and subsequently to their ability to escape the primary tumor, arguing for a pro tumorigenic function. Together with the fat body, they constitute the potential source of the AMP Drosomycin that is found elevated in the larval hemolymph. Drosomycin (Drs) triggers cell death in the tumor, arguing for a potential anti-tumorigenic role of the plasmatocytes. Wasting: Tumor cells secrete ImpL2 (and potentially Pvf and Bnl), which is thought to trigger a wasting phenotype in the larva characterized by the morphological deterioration of the energy-storing organs: the muscles (shrinkage and split) and the fat body (pearl-like phenotype, lipid droplet aggregation). This is accompanied by elevation of autophagy in these organs as well as elevated sugar and amino acid levels in the hemolymph. In its late stage, the tumor building blocks derive from host to maintain its growth.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 143 references

Cited by

See all 34

Metadata

Authors
Dillard, C., Reis, J. G. T., & Rusten, T. E.
Affiliations
  • Oslo University Hospital (NO)
  • Centre for Cancer Cell Reprogramming, Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
Corresponding author
  • Dillard, Caroline
  • Rusten, Tor Erik
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-08-18
Volume
22
Issue
16
Pages
8873
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3193347793
Cited by
34
References
143
Citations by year
2026: 8 · 2025: 12 · 2024: 7 · 2023: 5 · 2022: 2
FWCI
0.37
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
Norges Forskningsråd (262652, 276070)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
tumor microenvironment, tumor-host interaction, malignant transformation, cell proliferation and survival, basement membrane degradation, metastasis, tumor immune evasion, tumor progression
MeSH terms
Animals, Humans, Membrane Proteins, Mutation, Neoplasms, Signal Transduction, ras Proteins, Tumor Suppressor Proteins, Tumor Microenvironment, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RasV12; scrib−/− Tumors: A Cooperative Oncogenesis Model Fueled by Tumor/Host Interactions. https://app.cochat.ai/papers/10.3390/ijms22168873
The paper
Dillard, C., Reis, J. G. T., & Rusten, T. E. (2021). RasV12; scrib−/− Tumors: A Cooperative Oncogenesis Model Fueled by Tumor/Host Interactions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22168873

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.